How do I taper off Zoloft (sertraline) 50 mg per oral (po) daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Off Zoloft (Sertraline) 50 mg Daily

For a patient on sertraline 50 mg daily, reduce the dose by 25 mg every 2 weeks, then switch to 25 mg every other day for 2 weeks, followed by 25 mg every 4 days before complete discontinuation—this gradual taper over 10-14 days minimizes withdrawal symptoms. 1, 2

Recommended Tapering Protocol

The optimal approach involves a stepwise reduction:

  • Week 1-2: Reduce from 50 mg to 25 mg daily 2
  • Week 3-4: Take 25 mg every other day 2
  • Week 5-6: Take 25 mg every 4 days 2
  • Week 7: Complete discontinuation 2

This schedule aligns with guideline recommendations to taper antidepressants over 10-14 days to limit withdrawal symptoms 1, while incorporating the more gradual approach that has shown greater success in reducing discontinuation symptoms 2, 3.

Why This Taper Schedule Works

The hyperbolic reduction strategy is critical. Recent evidence demonstrates that SSRIs should be tapered hyperbolically (reducing by percentage of current dose, not original dose) and slowly to doses much lower than therapeutic minimums 3. This approach reduces the biological effect at serotonin transporters in a linear manner, minimizing withdrawal symptoms 3.

Sertraline's pharmacokinetics support this schedule. With an elimination half-life of 22-36 hours 4, sertraline clears relatively quickly compared to other SSRIs, making a 6-week taper appropriate for a 50 mg daily dose 5, 4.

Monitoring for Withdrawal Symptoms

Watch for these discontinuation symptoms:

  • Anxiety, tremor, insomnia, sweating 2
  • Headache, weakness, muscle aches 2
  • Nausea, dizziness, confusion 2
  • Gastrointestinal disturbances 5

Follow up at least every 2 weeks during the taper, with more frequent contact if withdrawal symptoms emerge 2. The taper rate must be determined by the patient's tolerance, not a rigid schedule—pauses are acceptable and often necessary when symptoms develop 2.

Critical Pitfalls to Avoid

Never discontinue abruptly. Abrupt discontinuation of antidepressants after prolonged use causes withdrawal syndromes and risks relapse or exacerbation of depression 6. This is equivalent to suddenly stopping antihypertensives or antihyperglycemics and is never appropriate 2.

Do not taper too quickly. While older guidelines recommended 2-4 week tapers to therapeutic minimum doses, studies show these brief tapers provide minimal benefit over abrupt discontinuation and are often not tolerated 3. Tapers over months to much lower doses have shown greater success 3.

If withdrawal symptoms emerge, slow the taper. Reduce by smaller increments (12.5 mg reductions or extending intervals between doses) and allow more time between reductions 2, 3.

Adjunctive Support Strategies

Consider integrating cognitive behavioral therapy (CBT) during the taper, as this significantly increases success rates 2. Additional supportive measures include:

  • Mindfulness and relaxation techniques 2
  • Sleep hygiene education 2
  • Exercise and fitness training 2
  • Patient education about SSRI withdrawal risks and benefits of gradual tapering 2

When to Refer to a Specialist

Immediate specialist referral is indicated for:

  • History of withdrawal seizures 2
  • Unstable psychiatric comorbidities 2
  • Co-occurring substance use disorders 2
  • Previous unsuccessful office-based tapering attempts 2

Special Considerations

For patients on sertraline longer than 1 year, consider extending the taper to 10% reductions per month rather than the standard schedule 2. This may require compounding pharmacy services to achieve very small dose reductions.

Sertraline has minimal drug interactions compared to other SSRIs due to less effect on cytochrome P450 metabolism 1, 4, making it safer to combine with adjunctive medications if needed for withdrawal symptom management.

The goal is durability of the taper, not speed 2. Tapers may be considered successful as long as the patient is making progress, even if it takes longer than initially planned 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Benzodiazepine Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacokinetics of sertraline.

Clinical pharmacokinetics, 2002

Research

Switching and stopping antidepressants.

Australian prescriber, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.